About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Expanded Access for IMMU-132

NCT04320693·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Gilead Sciences

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

\-

You may not be if

\-

The record

StatusApproved for marketing

PhaseNo phase

Taking part—

Started—

UpdatedAug 19, 2021

Conditions

Metastatic Triple-Negative Breast Carcinoma

Clareo Health | Expanded Access for IMMU-132